Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Grade 1 Follicular Lymphoma

Clinical trial condition

Recurrent Grade 1 Follicular Lymphoma

Explore clinical trials studying Recurrent Grade 1 Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

109 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Grade 1 Follicular Lymphoma trial results

Completed

Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma

NCT02049541

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +28 more
Locations: Emory University Atlanta, Georgia, United States

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT01261247

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +66 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma

NCT02037256

Conditions: Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, +130 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00536601

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +137 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma

NCT01258998

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +82 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

NCT01075321

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +59 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20

NCT03097770

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, +45 more
Locations: Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma

NCT00082888

Conditions: Anaplastic Large Cell Lymphoma, Chronic Disease, Disease Attributes, +37 more
Locations: University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

NCT00918333

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details